Bio-techne Corporation (NASDAQ:TECH)

CAPS Rating: 5 out of 5

The Company and its subsidiaries are engaged in the development and manufacture of biotechnology products and hematology calibrators and controls.

Results 1 - 20 of 32 : 1 2 Next »

Recs

0
Member Avatar Teacherman333 (66.60) Submitted: 6/1/2013 1:06:06 PM : Outperform Start Price: $65.78 TECH Score: +14.84

For reference point and to allow for comments by others. As of the end of March, 2013.

ROE 16.33%
Trailing PE 22.02
PB 3.41
Div yield 1.80%

Recs

1
Member Avatar Awebb30 (71.01) Submitted: 4/16/2012 11:40:59 PM : Outperform Start Price: $63.76 TECH Score: -3.49

Minneapolis company so it must be good. Time to buy.

Recs

0
Member Avatar Lants (46.95) Submitted: 7/28/2011 7:52:13 PM : Outperform Start Price: $72.06 TECH Score: -30.08

Sales have grown steadily while the cost of sales has decreased. Revenue and earnings have also increased over the past two years.

Recs

0
Member Avatar dmarkiv (< 20) Submitted: 5/10/2011 1:31:48 PM : Outperform Start Price: $75.27 TECH Score: -27.93

I have previously stated that I subscribe to MF to get their fundamental research information. Also if anyone wants to see my Technical approach on any of my listed stocks, visit manageyourowntrades.com. This and all the stocks I currently own are listed on the above web site.

Recs

0
Member Avatar FAOFool (76.75) Submitted: 4/18/2011 11:57:27 PM : Outperform Start Price: $69.83 TECH Score: -23.83

Demographics...just look at all those 'Doctor' shows on TV! We are definitely getting older as a society due to the population demographics and longer life span, but all these shows, and debate about healthcare, have everyone much more focused on healthcare.
TECH is a great company to capitalize on both, given its product breadth and solid financials.

Recs

0
Member Avatar jimmywells (< 20) Submitted: 4/10/2011 5:32:34 PM : Outperform Start Price: $69.93 TECH Score: -21.42

For all the reasons Tom gardner said plus I think there is going to be a boom in colleges and universities and a push by government which means...more research....more business for TECH

Recs

0
Member Avatar bluegillfish (73.80) Submitted: 4/7/2011 11:28:32 AM : Outperform Start Price: $70.60 TECH Score: -22.88

biotech growth for 50 years

Recs

0
Member Avatar BMunkers (57.25) Submitted: 3/30/2011 6:50:53 PM : Outperform Start Price: $67.76 TECH Score: -17.71

Ok!

Recs

0
Member Avatar boscoramsey (58.55) Submitted: 3/18/2011 1:48:59 PM : Outperform Start Price: $66.85 TECH Score: -21.12

Like their services and product line. Good market.

Recs

0
Member Avatar cmbourne (25.50) Submitted: 3/10/2011 2:02:14 PM : Outperform Start Price: $67.34 TECH Score: -19.47

wide moat, profitable,

Recs

0
Member Avatar LSchwab1 (< 20) Submitted: 2/24/2011 12:20:21 AM : Outperform Start Price: $66.95 TECH Score: -18.08

Biotech is growing and will accelerate. TECH helps others do what they do.

Recs

0
Member Avatar scavanna (61.06) Submitted: 2/23/2011 6:49:48 AM : Outperform Start Price: $67.36 TECH Score: -17.88

SA pick and moat

Recs

0
Member Avatar cashkid79 (94.58) Submitted: 2/23/2010 8:07:33 PM : Outperform Start Price: $58.69 TECH Score: -27.97

I like R&D in biotech. This is great exposure to the sector. Research/Development (and global presence) = Innovations/Patents/Profits - it just makes sense...LONG

Recs

0
Member Avatar iddqkfyou (< 20) Submitted: 2/8/2010 8:07:28 AM : Outperform Start Price: $57.17 TECH Score: -29.67

Two insider purchases at just under the current price. Fundamentals back it up. No, I don't care that it once again has bad technicals.

Recs

0
Member Avatar tpulley (25.12) Submitted: 3/21/2009 10:43:39 PM : Outperform Start Price: $48.09 TECH Score: -69.46

low debt, high free cash flow, great long term growth, strong competitive position

Recs

0
Member Avatar EruditeInvestor (49.32) Submitted: 3/8/2009 6:48:38 PM : Outperform Start Price: $42.77 TECH Score: -89.13

Techne Corp. (TECH) is a manufacturer of biotechnology products. The company has consistently grown earnings year each year since 1989. Currently, its latest 12 month's earnings are $2.82 and fiscal 2009 (June 30, 2009) should surpass last year's $2.64 by a substantial amount.

Recently, TECH instituted a dividend which currently yields 1.1% on its $46.98 price.
EVO = 10.00 and QVT Rating is a very high 9.91

Recs

0
Member Avatar becon800 (99.55) Submitted: 12/23/2008 3:03:04 PM : Outperform Start Price: $55.93 TECH Score: -76.15

No debt, increasing guidances, and < 50 day moving avg.

Recs

0
Member Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:47:04 PM : Outperform Start Price: $57.10 TECH Score: -102.47

ibd

Recs

0
Member Avatar Cuchulainn1 (< 20) Submitted: 7/10/2008 4:05:57 PM : Outperform Start Price: $71.56 TECH Score: -41.24

Biotech is back in fashion.

Recs

0
Member Avatar Salamatgod (< 20) Submitted: 5/19/2008 1:52:15 PM : Outperform Start Price: $68.72 TECH Score: -12.80

CONTINUE TO GROW

Results 1 - 20 of 32 : 1 2 Next »

Featured Broker Partners


Advertisement